IL-1 receptor antagonist, MIS-C, and the peculiar autoimmunity of SARS-CoV-2

Lancet Rheumatol. 2022 May;4(5):e305-e307. doi: 10.1016/S2665-9913(22)00090-X. Epub 2022 Mar 29.

Authors

Hamid Bassiri^{1

2}, Scott W Canna^{2

3}

Affiliations

¹ Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
² Immune Dysregulation, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
³ Rheumatology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

No abstract available

Grants and funding

R61 HD105594/HD/NICHD NIH HHS/United States